Stonepine Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Stonepine Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$4K	–	34
2021 Q2	$4K	Sell	1,000 -178,511	-99%	-$740K	﹤0.01%	25
2021 Q1	$910K	Buy	+179,511	New	+$931K	0.49%	26
2020 Q2	–	Sell	-586,969	Closed	-$1.93M	–	22
2020 Q1	$1.93M	Buy	+586,969	New	+$3.09M	2.04%	22

Other funds holding AGTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Stonepine Capital Management's AGTC Position: Q3 2021 in Review

Stonepine Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2021, closing a stake of 1,000 shares — an estimated $4K sold.

Stonepine Capital Management first reported a position in AGTC in Q1 2020 and held it in 3 quarters. The position peaked at $1.93M in Q1 2020. 64 funds tracked by Wall St. Rank hold AGTC as of Q3 2021.

Stonepine Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2021 after selling out during the quarter.
Stonepine Capital Management sold 1,000 Applied Genetic Technologies Corporation shares in Q3 2021, an estimated $4K.
Stonepine Capital Management first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 3 quarters.
Stonepine Capital Management's Applied Genetic Technologies Corporation position peaked at $1.93M in Q1 2020.
64 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2021.

Based on Stonepine Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.